The round, which takes Indee's equity total to $3.9m, featured Main Sequence Ventures.
2Indee Labs, a US-based genetic material chip developer based in part on research from University of South Australia (UniSA), received $2.6m on Thursday in a seed round led by VC firm Founders Fund.
Main Sequence Ventures, which manages the $150m Innovation Fund launched by Australian government-backed research network Commonwealth Scientific and Industrial Research Organisation (Csiro), backed the round together with unnamed angel investors.
Indee Labs is working on a microchip-based gene delivery platform based on an approach called microfluidic vortex…
